But I believe in sharing what has worked in my own experience, and then giving you the information to make your own educated decision
PMC 7013727
For instance, these measures include payment schemes, commercialization awards, patent purchases, and publicprivate partnerships in which public funding helps R&D at different development stages in pharmaceutical and biotech companies [61]
503A Compounding is Not Impacted by the FDA Decision, But Faces Uncertainties The FDAs decision not to include these GLP-1s on the bulk compounding list does not affect their use by 503A pharmacies which are permitted, subject to various requirements, to compound with active ingredients found in FDA-approved drug products

You should contact your GP or diabetes care team if you experience: Severe or persistent gastrointestinal symptoms , particularly if you have: Severe abdominal pain that does not improve Persistent vomiting that prevents you from keeping down food or fluids Signs of dehydration (dark urine, reduced urine output, dizziness, dry mouth) Symptoms suggestive of pancreatitis (severe, persistent abdominal pain radiating to the back, often accompanied by nausea and vomiting) Signs of gallbladder disease , including: Pain in the right upper abdomen Fever Yellowing of the skin or eyes (jaundice) Significant mood changes or mental health concerns , including: Persistent low mood, anxiety, or depression Mood swings that interfere with daily activities or relationships Thoughts of self-harm (seek urgent help via your GP, NHS 111, or emergency services) Recurrent hypoglycaemia , especially if you experience frequent episodes of low blood sugar or are unaware of warning symptoms